Koers CytRx Corporation OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 644K 0 593K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -4 mln. - -3,69 mln. | Nettowinst (verlies) 2023 | - - 0 | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,15 mln. 0 1,06 mln. | Nettoliquiditeiten 2023 | 2,04 mln. 0 1,88 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,05
x | K/w-verhouding 2023 |
1,91
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10-01-22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01-10-07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29-07-21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27-07-22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12-07-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 58,06 mld. | |
-5,31% | 40,53 mld. | |
+37,52% | 38,99 mld. | |
+14,75% | 26,7 mld. | |
-12,56% | 26,56 mld. | |
-22,45% | 18,98 mld. | |
+0,04% | 12,17 mld. | |
+25,12% | 12 mld. | |
+26,04% | 11,92 mld. |
- Beurs
- Aandelen
- Koers LADX
- Koers